CRIS Current Research Information System

SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.634
AS - Asia 20.732
EU - Europa 19.312
SA - Sud America 2.002
AF - Africa 1.411
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 20
Totale 74.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.387
SG - Singapore 6.117
CN - Cina 5.694
GB - Regno Unito 5.451
VN - Vietnam 4.387
DE - Germania 3.161
IT - Italia 2.781
SE - Svezia 1.922
HK - Hong Kong 1.721
BR - Brasile 1.529
RU - Federazione Russa 1.309
FR - Francia 1.237
IN - India 1.206
UA - Ucraina 1.168
IE - Irlanda 710
KR - Corea 545
ZA - Sudafrica 499
EE - Estonia 407
JP - Giappone 369
CI - Costa d'Avorio 327
SC - Seychelles 299
NL - Olanda 287
AR - Argentina 222
JO - Giordania 210
TG - Togo 181
AT - Austria 148
ID - Indonesia 123
FI - Finlandia 117
CA - Canada 114
BG - Bulgaria 107
MX - Messico 97
CH - Svizzera 94
EC - Ecuador 84
AU - Australia 72
BE - Belgio 71
PL - Polonia 71
GR - Grecia 57
ES - Italia 53
BD - Bangladesh 51
CO - Colombia 48
CL - Cile 38
LB - Libano 34
PY - Paraguay 33
TR - Turchia 32
PK - Pakistan 28
IL - Israele 26
IQ - Iraq 25
CZ - Repubblica Ceca 24
UZ - Uzbekistan 24
IR - Iran 22
MA - Marocco 20
LT - Lituania 19
PE - Perù 19
EG - Egitto 18
RO - Romania 17
MY - Malesia 15
VE - Venezuela 15
EU - Europa 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
NO - Norvegia 12
HU - Ungheria 11
NZ - Nuova Zelanda 11
AL - Albania 10
AZ - Azerbaigian 10
DK - Danimarca 10
PA - Panama 10
PH - Filippine 10
UY - Uruguay 10
HR - Croazia 9
KE - Kenya 9
PT - Portogallo 8
RS - Serbia 8
JM - Giamaica 7
KZ - Kazakistan 7
TW - Taiwan 7
KW - Kuwait 6
NG - Nigeria 6
NP - Nepal 6
SA - Arabia Saudita 6
SI - Slovenia 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
LV - Lettonia 5
MT - Malta 5
SK - Slovacchia (Repubblica Slovacca) 5
BW - Botswana 4
BY - Bielorussia 4
GE - Georgia 4
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
KG - Kirghizistan 3
KH - Cambogia 3
LK - Sri Lanka 3
SV - El Salvador 3
BN - Brunei Darussalam 2
Totale 74.143
Salva come PNG Salva come JPEG
Città #
Southend 4.806
Fairfield 4.502
Singapore 3.668
Ashburn 2.816
Woodbridge 2.109
Seattle 1.958
Wilmington 1.873
Houston 1.811
Santa Clara 1.717
Hong Kong 1.693
Cambridge 1.519
Chandler 1.259
Ann Arbor 1.256
Princeton 1.222
Hefei 1.208
Dong Ket 1.065
Ho Chi Minh City 922
Boardman 761
Jacksonville 733
Dublin 703
Hanoi 686
Beijing 589
Seoul 536
Westminster 510
Padova 469
Nanjing 458
Bologna 363
Berlin 357
Los Angeles 346
Dallas 331
Abidjan 327
Tokyo 308
Buffalo 284
San Diego 274
Saint Petersburg 271
Shenyang 222
Jinan 217
Amman 209
Redondo Beach 199
Milan 195
Mülheim 183
Lomé 181
Turin 181
Hebei 166
Nanchang 160
Changsha 148
São Paulo 132
Des Moines 124
Rome 123
Guangzhou 119
Bengaluru 116
Chicago 114
Tianjin 114
New York 111
Shanghai 102
Dearborn 100
Jiaxing 99
Sofia 99
Frankfurt am Main 94
Vienna 91
Haiphong 85
Mahé 81
Zhengzhou 81
Grafing 78
London 76
Nuremberg 72
Hangzhou 71
Da Nang 70
Jakarta 69
Falls Church 68
Helsinki 68
Norwalk 67
Yubileyny 65
Haikou 64
Olalla 64
Verona 60
Quận Bình Thạnh 57
Bern 56
Biên Hòa 56
Ha Long 55
Ningbo 55
Brussels 53
Phoenix 53
Rio de Janeiro 51
Redwood City 50
Kunming 46
Ninh Bình 46
Paris 46
Warsaw 46
Bühl 45
Hải Dương 45
Munich 45
Fuzhou 43
Falkenstein 42
Lappeenranta 41
Medford 40
Redmond 40
Taizhou 40
Thái Nguyên 40
San Venanzo 39
Totale 49.578
Salva come PNG Salva come JPEG
Nome #
Il suicidio assistito per pazienti con depressione grave. Un’opzione inaccettabile che gli psichiatri devono combattere fermamente 529
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 394
A molecular pathway analysis informs the genetic background at risk for schizophrenia 367
Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes 361
A genetic dissection of antipsychotic induced movement disorders. 324
5-HTTLPR and gender differences in affective disorders: A systematic review 308
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. 306
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 291
Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: Systematic review and indirect treatment comparison 263
Psychometric characteristic of the Italian version of the Temperament and Character Inventory-Revised (TCI-R). Personality, psychopathology and attachment styles 227
L'UTILITA' DELLE MEDITAZIONI BASATE SULLA CONSAPEVOLEZZA PER I DISTURBI PSICHIATRICI: UNA REVIEW SISTEMATICA 226
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes 223
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 217
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression 210
The 5-HT2C receptor as a target for mood disorders. 207
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 207
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. 204
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 201
Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient with Chronic Renal Failure: A Case Report 201
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 200
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 198
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 196
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 193
Metabolic risk factor profile associated with use of second generation antipsychotics: a cross-sectional study in a community mental health centre 186
A molecular pathway analysis of the glutamatergic–monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment 184
How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes 183
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 183
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 182
A model to investigate SNPs' interaction in GWAS studies 181
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 178
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. 178
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 178
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study 177
Social brain, social dysfunction and social withdrawal 177
A neural network model for combining clinical predictors of antidepressant response in mood disorders 176
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 175
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 175
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. 174
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 174
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder 174
5-HT(2A) SNPs and the Temperament and Character Inventory 173
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 173
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 171
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial 171
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 170
Benefit of slow titration of paroxetine to treat depression in the elderly 170
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 169
Antidepressants and body weight: a comprehensive review and meta-analysis 169
Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study 168
5-HT(1A) polymorphism and self-transcendence in mood disorders 168
The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression 168
A systematic review of neurobiological and clinical features of mindfulness meditations 166
Adenosine Hypothesis of Antipsychotic Drugs Revisited: Pharmacogenomics Variation in Nonacute Schizophrenia 166
Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders 165
A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population 165
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons 164
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples 164
Collaborative meta-Analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression 164
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes 163
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 162
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 162
The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis 162
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders 161
Cognitive markers of psychotic unipolar depression: A meta-analytic study 160
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder 159
Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders 159
Association between the estrogen receptor TA polymorphism and Harm avoidance 159
COMT and age at onset in mood disorders: a replication and extension study. 159
Depressive symptomatology is influenced by chronotypes 158
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 158
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 158
Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study 158
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 157
Personality and Genetics 156
Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation. 156
Thyroid hormones affect recovery from depression during antidepressant treatment 155
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 155
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 155
A new prediction model for evaluating treatment-resistant depression 154
Genome-wide association study identifies 30 loci associated with bipolar disorder 154
The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis 153
Components of self-esteem in affective patients and non-psychiatric controls 153
Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento 153
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome 153
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials 153
Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population. 152
Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects 152
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial 152
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 151
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 151
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 150
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. 150
Alexithymia: phisiopathology, etiology and management 150
Progress and prospects in pharmacogenetics of antidepressant drugs 150
Low comorbid obsessive-compulsive disorder in patients with major depressive disorder – Findings from a European multicenter study 150
Duloxetine plasma level and antidepressant response 150
A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. 149
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 149
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - A European multicentre study 148
Antidepressant response in the elderly. 147
Totale 18.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.552 0 0 0 0 0 305 140 582 678 422 348 2.077
2021/20229.193 922 346 678 569 879 569 272 794 311 909 1.658 1.286
2022/20238.083 927 1.151 477 840 509 506 328 456 1.449 242 792 406
2023/20242.414 155 408 196 210 190 373 180 201 106 204 86 105
2024/202511.880 277 1.949 855 815 2.512 695 743 300 213 563 613 2.345
2025/202614.785 2.651 3.030 3.019 2.486 2.716 883 0 0 0 0 0 0
Totale 75.334